Katy Lawson

Katy Lawson

Auto-generated profile, based on publicly available information

Katy Lawson

School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
JFJing Feng
Jing Feng
YZYonghui Zhao
Yonghui Zhao
ZXZili Xie
Zili Xie
KZKaikai Zang
Kaikai Zang
SSSanja Sviben
Sanja Sviben
HHHongzhen Hu
Hongzhen Hu
Itch sensation provokes the scratch reflex to protect us from harmful stimuli in the skin. Although scratching transiently relieves acute itch through activation of mechanoreceptors, it propagates the vicious itch-scratch cycle in chronic itch by further aggravating itch over time. Although well recognized clinically, the peripheral mechanisms underlying the itch-scratch cycle remain poorly understood. Here, we show that mechanical stimulation of the skin results in activation of the Piezo2 channels on Merkel cells that pathologically promotes spontaneous itch in experimental dry skin. Three-dimensional reconstruction and immunoelectron microscopy revealed structural alteration of MRGPRA3 + pruriceptor nerve endings directed toward Merkel cells in the setting of dry skin. Our results uncover a functional miswiring mechanism under pathologic conditions, resulting in touch receptors triggering the firing of pruriceptors in the skin to drive the itch-scratch cycle.

5 April 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HSHaley R. Steele
Haley R. Steele
YXYanyan Xing
Yanyan Xing
YZYuyan Zhu
Yuyan Zhu
HHHenry B. Hilley
Henry B. Hilley
KLKaty Lawson
Katy Lawson
LHLiang Han
Liang Han
Itch arising from glabrous skin (palms and soles) has attracted limited attention within the field due to the lack of methodology. This is despite glabrous itch arising from many medical conditions such as plantar and palmar psoriasis, dyshidrosis, and cholestasis. Therefore, we developed a mouse glabrous skin behavioral assay to investigate the contribution of three previously identified pruriceptive neurons in glabrous skin itch. Our results show that MrgprA3+ and MrgprD+ neurons, although key mediators for hairy skin itch, do not play important roles in glabrous skin itch, demonstrating a mechanistic difference in itch sensation between hairy and glabrous skin. We found that MrgprC11+ neurons are the major mediators for glabrous skin itch. Activation of MrgprC11+ neurons induced glabrous skin itch, while ablation of MrgprC11+ neurons reduced both acute and chronic glabrous skin itch. Our study provides insights into the mechanisms of itch and opens up new avenues for future glabrous skin itch research. Significance Chronic itch, associated with dermatologic or systemic diseases, is challenging to treat and significantly affects quality of life. In the past several decades, significant progress has been made to help us understand the mechanisms of itch. Due to the ease of application and analysis, all animal itch behavioral assays utilize pruritogens administered to the hairy skin. However, itch occurs to both hairy and hairless glabrous skin. Many medical conditions such as plantar and palmar psoriasis, dyshidrosis, and cholestasis mainly evoke itch in glabrous skin. We here present evidence demonstrating that distinct neuronal populations are responsible for mediating hairy and glabrous skin itch. This study advanced our understanding of itch and will have significant impact on the clinical treatment of itch.

1 May 2021 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YXYanyan Xing
Yanyan Xing
HSHaley R. Steele
Haley R. Steele
HHHenry B. Hilley
Henry B. Hilley
YZyuyan zhu
yuyan zhu
KLKaty Lawson
Katy Lawson
LHLiang Han
Liang Han

1 April 2025 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
YXYanyan Xing
Yanyan Xing
YNYeseul Nho
Yeseul Nho
KLKaty Lawson
Katy Lawson
YZyuyan zhu
yuyan zhu
AEAlexandra E. Ellison
Alexandra E. Ellison
LHLiang Han
Liang Han
The lung is densely innervated by sensory nerves, the majority of which are derived from the vagal sensory neurons. Vagal ganglia consist of two different ganglia, termed nodose and jugular ganglia, with distinct embryonic origins, innervation patterns, and physiological functions in the periphery. Because nodose neurons constitute the majority of the vagal ganglia, our understanding of the function of jugular nerves in the lung is very limited. This study aims to investigate the role of MrgprC11+ jugular sensory neurons in a mouse allergic asthma model. Our previous study has shown that MrgprC11+ jugular neurons mediate cholinergic bronchoconstriction. In this study, we found that, in addition to MrgprC11, several other Mrgpr family members, including MrgprA3, MrgprB4, and MrgprD, are also specifically expressed in the jugular sensory neurons. MrgprC11+ jugular neurons exhibit dense innervation in the respiratory tract, including the larynx, trachea, proximal bronchus, and distal bronchus. We also found that receptors for IL-4 and oncostatin M, two critical cytokines promoting allergic airway inflammation, are mainly expressed in jugular sensory neurons. Both IL-4 and oncostatin M can sensitize the neuronal responses of MrgprC11+ jugular neurons. Moreover, ablation of MrgprC11+ neurons significantly inhibited airway hyperresponsiveness in the asthmatic lung, demonstrating the critical role of MrgprC11+ neurons in controlling airway constriction. Our results emphasize the critical role of jugular sensory neurons in respiratory diseases and present MrgprC11+ neurons as a potential therapeutic target for treating airway hyperresponsiveness.

10 May 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YXYanyan Xing
Yanyan Xing
YNYeseul Nho
Yeseul Nho
KLKaty Lawson
Katy Lawson
HSHaley Steele
Haley Steele
LHLiang Han
Liang Han

21 November 2024 in JID Innovations
Verified
Journal Article
Open access
OOOlive C. Osuoji
Olive C. Osuoji
TDTaryn DeGrazia
Taryn DeGrazia
RRRobin Rolader
Robin Rolader
ECEmily F. Cole
Emily F. Cole
KLKaty Lawson
Katy Lawson
RFRon J. Feldman
Ron J. Feldman
Bullous pemphigoid is a devastating autoimmune blistering disease with need for improved therapeutics. Limited data are available on the overall burden of pruritus and alterations over time; however, treatment of itch-specific pathways may provide novel therapeutics. In this paper, we analyzed the QOL impact particularly related to itch and determined corresponding changes in intraepidermal nerve fiber density and gene expression. A total of 43 patients with bullous pemphigoid were followed prospectively on standard-of-care treatment and showed average Bullous Pemphigoid Disease Area Index total activity score decrease from 19.1 ± 19.2 to 8.2 ± 11.3 and improvement in QOL measures Autoimmune Bullous Disease Quality of Life, Treatment of Autoimmune Bullous Disease Quality of Life, and ItchyQoL. At baseline, intraepidermal nerve fiber density in patients with bullous pemphigoid and atopic dermatitis were significantly lower than in healthy controls (7.3 ± 1.5 and 3.2 ± 2.0 vs 9.7 ± 5.4 fibers/mm, P = .031) and increased from baseline to follow-up visit (11.7 ± 0.4 and 5.8 ± 2.7), although only atopic dermatitis reached statistical significance (P = .018). S100A8, S100A9, CCL17, and CCL18 genes were highly upregulated in the skin of patients with bullous pemphigoid compared with those in healthy controls. Our data provide evidence for improvements in itch-related QOL over time on standard-of-care therapies with unique alterations in inflammatory mediators related to early immune cell activation and recruitment.